Developing new therapeutic strategies for brain cancer

  • Johns, Terrance, (Chief Investigator)

Project Details

StatusActive
Effective start/end date1/01/1831/12/21

Funding

  • National Health & Medical Research Council NHMRC

Research Output

Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3

Greenall, S. A., Donoghue, J., Johns, T. G. & Adams, T. E., 1 Aug 2018, In : Translational Oncology. 11, 4, p. 971-978 8 p.

Research output: Contribution to journalArticle

Open Access
  • 2 Citations (Scopus)

    Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma

    Greenall, S. A., Lim, Y. C., Mitchell, C. B., Ensbey, K. S., Stringer, B. W., Wilding, A. L., O'Neill, G. M., McDonald, K. L., Gough, D. J., Day, B. W. & Johns, T. G., 15 May 2017, In : Oncogenesis. 6, e336.

    Research output: Contribution to journalArticle

    Open Access
  • 26 Citations (Scopus)